Consortium Clinical Research Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 18 Year,
- Last Filing with ROC 31 Mar 2023
- Revenue 2.14%
(FY 2020)
- Profit 10.75%
(FY 2020)
- Ebitda -158.96%
(FY 2020)
- Net Worth -40.93%
(FY 2020)
- Total Assets -3.27%
(FY 2020)
About Consortium Clinical Research
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nagalakshm Thirvvenkataswamy and Anandapadmanabhan Swamy serve as directors at the Company.
- CIN/LLPIN
U24233DL2007PTC157999
- Company No.
157999
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jan 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Consortium Clinical Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anandapadmanabhan Swamy  | Managing Director | 16-Jan-2007 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nagalakshm Thirvvenkataswamy | Director | 16-Jan-2007 | Current |
Financial Performance of Consortium Clinical Research.
Consortium Clinical Research Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.14% increase. The company also saw a substantial improvement in profitability, with a 10.75% increase in profit. The company's net worth observed a substantial decline by a decrease of 40.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Consortium Clinical Research?
In 2020, Consortium Clinical Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Swen Sante Medical Management Services L LpActive 7 yearsAnandapadmanabhan Swamy is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Consortium Clinical Research?
Unlock and access historical data on people associated with Consortium Clinical Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Consortium Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Consortium Clinical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
